[go: up one dir, main page]

AU2001266218A1 - Process for preparing and harvesting crystalline particles - Google Patents

Process for preparing and harvesting crystalline particles

Info

Publication number
AU2001266218A1
AU2001266218A1 AU2001266218A AU6621801A AU2001266218A1 AU 2001266218 A1 AU2001266218 A1 AU 2001266218A1 AU 2001266218 A AU2001266218 A AU 2001266218A AU 6621801 A AU6621801 A AU 6621801A AU 2001266218 A1 AU2001266218 A1 AU 2001266218A1
Authority
AU
Australia
Prior art keywords
preparing
crystalline particles
harvesting
harvesting crystalline
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266218A
Other languages
English (en)
Inventor
Robert William Lancaster
Hardev Singh
Andrew Lewis Theophilus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001266218A1 publication Critical patent/AU2001266218A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU2001266218A 2000-06-29 2001-06-29 Process for preparing and harvesting crystalline particles Abandoned AU2001266218A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0015981 2000-06-29
GBGB0015981.4A GB0015981D0 (en) 2000-06-29 2000-06-29 Novel process for preparing crystalline particles
PCT/GB2001/002922 WO2002000198A1 (fr) 2000-06-29 2001-06-29 Procede de preparation et de collecte de particules cristallines

Publications (1)

Publication Number Publication Date
AU2001266218A1 true AU2001266218A1 (en) 2002-01-08

Family

ID=9894682

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266218A Abandoned AU2001266218A1 (en) 2000-06-29 2001-06-29 Process for preparing and harvesting crystalline particles

Country Status (9)

Country Link
US (1) US20030181432A1 (fr)
EP (1) EP1294359B1 (fr)
JP (1) JP2004500983A (fr)
AT (1) ATE322252T1 (fr)
AU (1) AU2001266218A1 (fr)
DE (1) DE60118558T2 (fr)
ES (1) ES2260236T3 (fr)
GB (1) GB0015981D0 (fr)
WO (1) WO2002000198A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002094238A1 (fr) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Apport de composes anti-migraine par voie d'inhalation
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US6759029B2 (en) 2001-05-24 2004-07-06 Alexza Molecular Delivery Corporation Delivery of rizatriptan and zolmitriptan through an inhalation route
AU2002310074B2 (en) * 2001-05-24 2008-09-04 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of migraine through an inhalation route
CA2446904A1 (fr) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Administration d'esters medicamenteux par inhalation
WO2002094243A1 (fr) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Administration de sumatriptan, de frovatriptan ou de naratriptan par voie d'inhalation
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US20030049323A1 (en) * 2001-08-29 2003-03-13 Hitt James E. Process to precipitate drug particles
GB0208608D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Composition
ITMI20022674A1 (it) * 2002-12-18 2004-06-19 Chiesi Farma Spa Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.
JP4748584B2 (ja) * 2003-01-31 2011-08-17 水ｉｎｇ株式会社 晶析法による液中イオンの除去方法及び装置
WO2004076403A1 (fr) * 2003-02-24 2004-09-10 Transform Pharmaceuticals, Inc. Formes cristallines du sumatriptan, compositions pharmaceutiques et procedes
EP1625336B9 (fr) 2003-05-21 2012-03-21 Alexza Pharmaceuticals, Inc. Utilisation d'une couche de combustible solide, procédé pour fabriquer une telle couche et unité de chauffage correspondante
GB0406069D0 (en) * 2004-03-17 2004-04-21 Thompson James Process
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
WO2006010078A2 (fr) * 2004-07-08 2006-01-26 Dr. Reddy's Laboratories Ltd. Forme polymorphe de chlorhydrate de naratriptane
AU2004322756B2 (en) 2004-08-12 2011-04-14 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
US8420122B2 (en) 2006-04-28 2013-04-16 Merck Sharp & Dohme Corp. Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
JP5592647B2 (ja) * 2006-04-28 2014-09-17 メルク・シャープ・アンド・ドーム・コーポレーション 制御された析出による６，６−ジメチル−３−アザ−ビシクロ［３．１．０］ヘキサン−アミド化合物の析出および単離のための方法、ならびにこれを含む医薬処方物
JP2010500356A (ja) * 2006-08-09 2010-01-07 グラクソ グループ リミテッド ラクトースの製造方法
WO2008112661A2 (fr) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Unité chauffante à utiliser dans un dispositif d'administration de médicament
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
GB2477030A (en) * 2010-01-15 2011-07-20 Lithera Inc Lyophilised forms of fluticasone, salmeterol and combinations thereof
WO2013009591A1 (fr) * 2011-07-08 2013-01-17 Pfizer Limited Procédé de préparation du propionate de fluticasone, forme 1
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
PL3517541T3 (pl) 2012-05-08 2020-12-28 Nicox Ophthalmics, Inc. Postać polimorficzna propionianu flutykazonu
EP2705838A1 (fr) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Préparations de tiotropium
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
JP2018126699A (ja) * 2017-02-09 2018-08-16 水ｉｎｇ株式会社 晶析方法及び晶析装置
EP3746138B1 (fr) 2018-02-02 2025-12-10 Alexza Pharmaceuticals, Inc. Dispositif aérosol à condensation électrique

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3154395A (en) * 1961-01-30 1964-10-27 Universal Oil Prod Co Continuous fractional crystallization process
US3984409A (en) * 1973-08-09 1976-10-05 Pfizer Inc. Cyclic n-substituted derivatives of 1,4-benzene disulphonamide
NL7501406A (en) * 1975-02-06 1976-08-10 Dso Pharmachim Crystallisation of tetracycline hydrochloride - accelerated by subjecting to high-frequency vibrations, with purer, less toxic prod. formed
IE67187B1 (en) * 1990-06-15 1996-03-06 Merck & Co Inc A crystallization method to improve crystal structure and size
GB9313650D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
EA002039B1 (ru) * 1997-09-03 2001-12-24 Мерк Энд Ко., Инк. Способ повышения оптической чистоты 2r-[1-гидрокси-1-трифторметил-3-циклопропилпропин-2-ил]-4-хлоранилина
KR20010033747A (ko) * 1997-12-29 2001-04-25 태듀스 피. 프러스 Ｎ-Ｈｅｔ-치환 글리세로포스포에탄올아민
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
EP1026174B1 (fr) * 1998-08-31 2005-05-18 Nof Corporation Polysaccharide a haut degre de purete contenant des groupes hydrophobes et procede de production de ce polysaccharide
SE9802974D0 (sv) * 1998-09-03 1998-09-03 Astra Ab New crystalline forms
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
AU755470B2 (en) * 1999-01-29 2002-12-12 Bristol-Myers Squibb Company Sonic impinging jet crystallization apparatus and process

Also Published As

Publication number Publication date
US20030181432A1 (en) 2003-09-25
DE60118558T2 (de) 2006-08-24
JP2004500983A (ja) 2004-01-15
EP1294359B1 (fr) 2006-04-05
ATE322252T1 (de) 2006-04-15
EP1294359A1 (fr) 2003-03-26
ES2260236T3 (es) 2006-11-01
DE60118558D1 (de) 2006-05-18
WO2002000198A1 (fr) 2002-01-03
GB0015981D0 (en) 2000-08-23

Similar Documents

Publication Publication Date Title
AU2001266219A1 (en) Novel process for preparing and harvesting crystalline particles
AU2001266218A1 (en) Process for preparing and harvesting crystalline particles
HK1038709A1 (zh) 製備結晶顆粒的設備和方法
CA2425005A1 (fr) Procede de preparation de formulations pulverulentes
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
AU4107300A (en) Polyurethane solutions containing alkoxysilane structural units
WO2002047668A3 (fr) Nouvelles compositions medicamenteuses a base d'anticholinergiques et de ciclesonide
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
AU8974298A (en) 1,4,7,10-tetraazabicyclo{8.2.2}tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles
WO1999054315A3 (fr) Triazolones a effet neuroprotecteur
AU6578400A (en) Novel method for preparing benzoperhydroisoindole compounds
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
BG106002A (en) Process for preparing pesticidal intermediates
WO2001049651A3 (fr) Derives d'aminomethyle-phenyle-cyclohexane
AU3822900A (en) Process for the treatment of fly ash, using hydrochloric acid
AU2002330042A1 (en) Process for the preparation of 1,5-diarylpyrazoles
YU70502A (sh) Amorfna modifikacija torasemida
AU5419699A (en) Methoximinophenylacetic acid amides
AU4950597A (en) Composition containing chitosan
AU2003244235A1 (en) Process for preparation of optically active 1-substituted amino-2,3-epoxypropanes, intermediates for the synthesis thereof and process for preparation of the intermediates
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
YU67203A (sh) Derivati caloporosida, postupak za njihovu proizvodnju i njihova primena
AU5219700A (en) Halopyrimidines
AU1298800A (en) Process of preparing a high-energy softening agent
AU2910800A (en) Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines